West China Hospital, Sichuan University

What West China Hospital, Sichuan University does

West China Hospital, Sichuan University (四川大学华西医院) is a public tertiary teaching hospital founded in 1892 in Chengdu, China, affiliated with Sichuan University since the 2000 merger. It operates one of China's largest clinical footprints: 4,900+ licensed beds across multiple Chengdu campuses (Main, Wenjiang, Jinjiang, Tianfu, Shangjin) and a national network of subsidiary hospitals in Xiamen (Fujian), Tibet, and Hainan's Boao Lecheng International Medical Tourism Pilot Zone. The institution functions simultaneously as a national center for difficult and critical disease treatment, a teaching platform for 7,100+ medical students across undergraduate, graduate, residency, and continuing education programs, and a top-tier research enterprise — ranked #1 nationally in China Hospital Science and Technology Impact for seven consecutive years and Nature INDEX rank 26 globally.

Its clinical portfolio is anchored by several proprietary, high-volume specialty programs: Professor Liu Lunxu's unidirectional VATS lobectomy (adopted by 93.1% of Chinese hospitals performing thoracoscopic surgery); Professor Chen Mao's TAVI program (550+ procedures, 98%+ success rate, among the highest global volumes of bicuspid aortic valve cases); the LPD "double lead surgeon" laparoscopic pancreaticoduodenectomy model (570+ cases, world-leading 0.87% 90-day mortality); and an integrated TCM-Western medicine protocol for acute pancreatitis treating 2,000+ cases annually — claimed as the world's largest treatment center. The research infrastructure includes 9 national-level platforms (including the State Key Laboratory of Biotherapy), a 260,000+ sqm independent research campus, and annual research project funding exceeding 10 billion CNY.

Revenue is generated through three streams: clinical medical services (outpatient, inpatient, surgical, diagnostic) delivered across all campuses and through a 729-hospital medical alliance spanning 26 provinces; healthcare industry operations via subsidiaries including Sichuan Huaxi Health Technology, Chengdu Likang Industrial, and Chengdu Huaxi Haixu Pharmaceutical Technology (pharmaceutical sales, medical device distribution, healthcare products); and medical education and training revenue from postgraduate programs, standardized residency training, and the Huaxi Cloud Classroom continuing education platform (1,600+ sessions, 10 million person-times). Patient acquisition is reputation-driven rather than marketing-led, relying on word-of-mouth, medical alliance referrals, and the institution's national ranking profile. Pricing follows China's public hospital fee schedules under national medical insurance, with separate Special/VIP outpatient tiers and an International Healthcare Center for foreign patients.

Name

West China Hospital, Sichuan University

Legal name

四川大学华西医院 (West China Hospital, Sichuan University)

Website

https://wchscu.cn

Company type

Private

Founded year

1892

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

West China Hospital, Sichuan University is a 1892-founded public tertiary teaching hospital in Chengdu, China, operating 4,900+ beds across multiple campuses and serving as a national center for complex clinical care, medical education (7,100+ students), and top-ranked research (Nature INDEX top 30 globally, #1 in China hospital science impact for 7 consecutive years).

Ownership category

akta.pro rank

Product category

Tertiary Hospital Services

NAICS

General Medical and Surgical Hospitals (6221), General Medical and Surgical Hospitals (622110), Colleges, Universities, and Professional Schools (6113)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Health Services (8000), Services-Educational Services (8200)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC), Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC), Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

Keywords

• Tertiary hospital services
• Comprehensive medical care
• Medical education training
• Minimally invasive surgery
• Organ transplantation

Headquarters

HQ city

Chengdu

HQ country

China

HQ region

Asia

Offices8 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Medical Services Revenue: As a public tertiary teaching hospital, West China Hospital generates revenue primarily through patient medical services including outpatient consultations, inpatient care, surgical procedures, diagnostic services, and specialized treatments across its multiple campuses.
2. Healthcare Industry Operations: Subsidiary companies including Sichuan Huaxi Health Technology Co., Ltd., Chengdu Likang Industrial Co., Ltd., and Chengdu Huaxi Haixu Pharmaceutical Technology Co., Ltd. handle pharmaceutical sales, medical device distribution, healthcare product sales, and external investment operations.
3. Medical Education and Training: Revenue from postgraduate medical education, standardized residency training, specialized nurse training programs, and continuing medical education programs for healthcare professionals nationwide.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

West China Hospital, Sichuan University operates as a national-level comprehensive medical center delivering integrated clinical care, medical education, and scientific research. It provides tertiary-level diagnosis and treatment across numerous specialties (oncology, thoracic surgery, hepatobiliary surgery, cardiology, organ transplantation, trauma, etc.) across multiple campuses, alongside medical degree programs, residency training, and continuing medical education.

Product overview

West China Hospital operates as a comprehensive medical institution offering a wide range of clinical services, medical education, and scientific research. The hospital provides tertiary medical services through multiple specialized departments and centers, including cancer centers (lung, gastric, colorectal, breast), organ transplantation (kidney, liver), trauma medicine, and minimally invasive surgical techniques. Patient care is delivered through various service models including MDT clinics, expert team consultations, and comprehensive care management programs. Digital services are accessible through the Huayitong mobile application and telemedicine platforms.

Differentiator

Problem solved

Functional benefit

Products and services

• Unidirectional VATS Lobectomy (单向式胸腔镜肺叶切除术) A minimally invasive thoracoscopic lung cancer resection technique pioneered by Professor Liu Lunxu's team, using single-point unidirectional dissection; improved 5-year survival for Stage I lung cancer from 73.5% to 83.8%.
• Transcatheter Aortic Valve Implantation (TAVI / 经导管主动脉瓣置换术) Minimally invasive aortic valve replacement for elderly high-risk patients with aortic valve stenosis or regurgitation, performed without open-chest surgery.
• Laparoscopic Pancreaticoduodenectomy (腹腔镜胰十二指肠切除术) Advanced laparoscopic Whipple procedure performed by the Hepatobiliary Pancreatic Minimally Invasive Center, among the highest-volume centers globally with world-leading 90-day mortality of 0.87%.
• Integrated Traditional Chinese and Western Medicine Treatment for Acute Pancreatitis (中西医结合治疗急性胰腺炎) Combined TCM-Western medicine approach to acute pancreatitis treatment, serving over 2,000 cases annually at the world's largest such treatment center.
• Organ Transplant Center (器官移植中心) Comprehensive transplant services including kidney transplantation (5,000+ cases since 1978) and liver transplantation (1,600+ cases since 1979 with 5-year survival rate approaching 80%).
• Digestive Tract Early Cancer and Biliary-Pancreatic Minimally Invasive Treatment (消化道早癌及胆胰微创治疗) Advanced endoscopic techniques for early gastrointestinal cancers and biliary-pancreatic diseases, led by Professor Hu Bing's team.
• Multi-Disciplinary Team Clinic / MDT (多学科联合门诊) Consultation service where two or more specialists jointly discuss complex patient cases to establish definitive diagnoses and optimal treatment plans.
• Rare Disease Diagnosis and Treatment Center (罕见病诊疗中心) Specialized center coordinating rare disease consultations, diagnosis, research, and patient management across multiple disciplines.
• Two-Way Referral System (双向转诊) Referral coordination providing green channels for patients from grassroots institutions and facilitating rehabilitation transfers back to local hospitals.
• Integrated Care Management Center (患者全程管理中心) Comprehensive patient management system leveraging 5G platforms and multi-hospital data connectivity to provide full-cycle, standardized chronic disease management.
• Wound Treatment Center (伤口治疗中心) Advanced wound care center with international wound specialists treating over 50,000 cases annually, serving as a major training base for wound care professionals nationwide.
• Trauma Medical Center (创伤医学中心) Comprehensive trauma center established in 2019 with six subspecialties (orthopedic, neurological, geriatric, pediatric, emergency, trauma ICU), featuring 5G-enabled pre-hospital emergency response and multidisciplinary rapid response systems.
• Health Management Center (健康管理中心) Comprehensive health examination and management center offering one-stop services with electronic health records, post-examination medical support, and health promotion programs.
• Huayitong App (华医通) Mobile application for appointment booking, medical services, and patient communication, serving as the primary digital channel for accessing hospital services.
• Telemedicine Services (远程医疗服务) Remote medical consultation and healthcare services connecting the hospital with distant patients and affiliated institutions through digital platforms.

Quantifiable outcome

• TAVI success rate exceeds 98%
• +6 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators13 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Huashan Hospital, Fudan University: A top-ranked comprehensive AMC affiliated with Fudan University in Shanghai, providing multi-specialty tertiary care, graduate medical education, and clinical research. Closely comparable in academic mission, scale, and reputation to West China Hospital.
• The First Affiliated Hospital of Sun Yat-sen University: Comprehensive AMC in Guangzhou affiliated with Sun Yat-sen University, with strong research output and clinical specialty depth. Comparable as a Tier-1 Chinese university teaching hospital serving regional + national patient flows.
• Peking Union Medical College Hospital (PUMCH): China's most prestigious comprehensive academic medical center under the Chinese Academy of Medical Sciences. Operates as a national tertiary teaching hospital with comparable integrated clinical, research, and teaching missions and similar pioneering-specialty focus.
• The First Affiliated Hospital of Zhejiang University: Provincial-level comprehensive AMC and teaching hospital in Hangzhou under Zhejiang University, operating across multiple campuses with similarly broad specialty coverage and research platforms.
• Qilu Hospital, Shandong University: Comprehensive AMC under Shandong University in Jinan, with similar multi-campus structure and strong research/clinical integration. Directly comparable in patient catchment and academic medical mission.
• Tongji Hospital, Tongji Medical College (HUST): Comprehensive AMC under Huazhong University of Science and Technology in Wuhan with similar multi-campus structure, large specialty centers, and high-impact research profile. Directly comparable in scale and academic-clinical integration.
• Ruijin Hospital, Shanghai Jiao Tong University School of Medicine: Renowned Shanghai-based comprehensive AMC affiliated with Shanghai Jiao Tong University, known for clinical research excellence and integrated medical education. Directly comparable in tertiary care + research mission.
• Xiangya Hospital, Central South University: Comprehensive AMC in Changsha affiliated with Central South University with similar 100+ year history, multi-campus footprint, and national reputation for complex-case treatment and research.
• Zhongshan Hospital, Fudan University: Shanghai-based comprehensive AMC under Fudan University, operating as a multi-specialty tertiary hospital with strong cardiovascular and oncology programs. Comparable in academic and clinical positioning.

Broad incumbents

• Mayo Clinic: Global benchmark for integrated academic medical center model combining clinical care, research, and education. Relevant as a global aspirational benchmark and indirect model for the integrated AMC operating model West China Hospital follows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ihuaxi
• Facebookfacebook.com/West-China-Hospital-100093199759689
• LinkedInlinkedin.com/company/west-china-hospital

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about West China Hospital, Sichuan University